These outcomes provide evidence that YY1 serves as a functional collaborator with HDAC2 in the migration of lung adenocarcinoma cells, and emphasize the potential for targeting HDAC2-YY1 interactions as a means of developing innovative therapeutic approaches. This evidence concerns the gene YY1 and lung adenocarcinoma.